GNRH1 and neoplasm: Regarding targeting units, several native and synthetic GnRH analogs have been shown to efficiently affect only the tumor cells with a GnRH receptor (GnRH-R) and spare the healthy cells with no or a limited number of GnRH-Rs [2,3].